Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T26368 | Target Info | |||
Target Name | GABA(A) receptor alpha-5 (GABRA5) | ||||
Synonyms |
GABRA5; GABAA alpha 5; GABA-A alpha-5
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | GABRA5 | ||||
Biochemical Class | Ligand-gated ion channel | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | GABA(A) receptor alpha-1 (GABRA1) | Successful Target | ||||
UniProt ID | GBRA1_HUMAN | |||||
Gene Name | GABRA1 | |||||
Synonyms |
Gamma-aminobutyric acid receptor subunit alpha-1; GABA(A) receptor subunit alpha-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 3.3 nM | Click to Show More | [1] | |
2 | Basmisanil | Drug Info | Ki = 985 nM | [3] | ||
Co-Target Name | Gamma-aminobutyric acid B receptor (GABBR) | Successful Target | ||||
UniProt ID | GABR1_HUMAN; GABR2_HUMAN | |||||
Gene Name | GABBR1; GABBR2 | |||||
Synonyms |
Gamma-aminobutyric acid type B receptor; GPRC3; GABABR; GABA-BR; GABA-B-R; GABA-B receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | GSK683699 | Drug Info | IC50 = 25 nM | [2] | ||
Co-Target Name | GABA(A) receptor alpha-3 (GABRA3) | Successful Target | ||||
UniProt ID | GBRA3_HUMAN | |||||
Gene Name | GABRA3 | |||||
Synonyms |
Gamma-aminobutyric acid receptor subunit alpha-3; GABA-A receptor alpha 3; GABA(A)Gamma-aminobutyric-acid receptor alpha-3 subunit precursor receptor; GABA(A) receptor subunit alpha-3
Click to Show/Hide
|
|||||
Representative Drug(s) | Basmisanil | Drug Info | Ki = 489 nM | [3] | ||
Co-Target Name | GABA(A) receptor alpha-2 (GABRA2) | Successful Target | ||||
UniProt ID | GBRA2_HUMAN | |||||
Gene Name | GABRA2 | |||||
Synonyms |
GABRA2; GABA-A receptor alpha 2; GABA(A)Gamma-aminobutyric-acid receptor alpha-2 subunit precursor receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Basmisanil | Drug Info | Ki = 502 nM | [3] | ||
Co-Target Name | GABA transporter-3 (SLC6A11) | Clinical trial Target | ||||
UniProt ID | S6A11_HUMAN | |||||
Gene Name | SLC6A11 | |||||
Synonyms |
Solute carrier family 6 member 11; Sodium- and chloride-dependent GABA transporter 3; GAT3; GAT-3; GABT3
Click to Show/Hide
|
|||||
Representative Drug(s) | GSK683699 | Drug Info | IC50 = 1000 nM | [4] | ||
Co-Target Name | GABA(A) receptor rho1 (GABRR1) | Literature-reported Target | ||||
UniProt ID | GBRR1_HUMAN | |||||
Gene Name | GABRR1 | |||||
Synonyms |
Gamma-aminobutyric acid receptor subunit rho-1; GABA(C) receptor1; GABA(A) receptor subunit rho-1
Click to Show/Hide
|
|||||
Representative Drug(s) | GSK683699 | Drug Info | EC50 = 269.15 nM | [5] | ||
Co-Target Name | Na(+)/Cl(-) betaine/GABA transporter (SLC6A12) | Literature-reported Target | ||||
UniProt ID | S6A12_HUMAN | |||||
Gene Name | SLC6A12 | |||||
Synonyms |
Solute carrier family 6 member 12; Sodium- and chloride-dependent betaine transporter; BGT-1
Click to Show/Hide
|
|||||
Representative Drug(s) | GSK683699 | Drug Info | IC50 = 851.14 nM | [4] | ||
Co-Target Name | GABA A receptor alpha-1/beta-2/gamma-2 (GABRA1/GABRB2/GABRG2) | Co-Target | ||||
UniProt ID | GBRA1_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA1-GABRB2-GABRG2 | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 0.8 nM | Click to Show More | [6] | |
2 | Flumazenil | Drug Info | Ki = 0.8 nM | [6] | ||
Co-Target Name | GABA A receptor alpha-2/beta-3/gamma-2 (GABRA2/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA2_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA2-GABRB3-GABRG2 | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 0.9 nM | [7] | ||
Co-Target Name | GABA A receptor alpha-3/beta-3/gamma-2 (GABRA3/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA3_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA3-GABRB3-GABRG2 | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 1.05 nM | [6] | ||
Co-Target Name | GABA receptor alpha-4 (GABRA4) | Co-Target | ||||
UniProt ID | GBRA4_HUMAN | |||||
Gene Name | GABRA4 | |||||
Synonyms |
Gamma-aminobutyric acid receptor subunit alpha-4; GABA(A) receptor subunit alpha-4
Click to Show/Hide
|
|||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 2 nM | [1] | ||
Co-Target Name | GABA A receptor alpha-2/beta-2/gamma-2 (GABRA2/GABRB2/GABRG2) | Co-Target | ||||
UniProt ID | GBRA2_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA2-GABRB2-GABRG2 | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 5.7 nM | Click to Show More | [1] | |
2 | GSK683699 | Drug Info | EC50 = 650 nM | [9] | ||
Co-Target Name | GABA A receptor alpha-3/beta-2/gamma-2 (GABRA3/GABRB2/GABRG2) | Co-Target | ||||
UniProt ID | GBRA3_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA3-GABRB2-GABRG2 | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 8.1 nM | Click to Show More | [1] | |
2 | GSK683699 | Drug Info | EC50 = 912.01 nM | [5] | ||
Co-Target Name | GABA A receptor alpha-6/beta-3/gamma-2 (GABRA6/GABRB3/GABRG2) | Co-Target | ||||
UniProt ID | GBRA6_HUMAN-GBRB3_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA6-GABRB3-GABRG2 | |||||
Representative Drug(s) | Flumazenil | Drug Info | Ki = 148 nM | [6] | ||
Co-Target Name | GABA A receptor alpha-5/beta-2/gamma-2 (GABRA5/GABRB2/GABRD2) | Co-Target | ||||
UniProt ID | GBRA5_HUMAN-GBRB2_HUMAN-GBRG2_HUMAN | |||||
Gene Name | GABRA5-GABRB2-GABRG2 | |||||
Representative Drug(s) | GSK683699 | Drug Info | EC50 = 230 nM | [8] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different. J Med Chem. 2008 Nov 27;51(22):7243-52. | ||||
REF 2 | Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists. J Med Chem. 1995 Aug 18;38(17):3297-312. | ||||
REF 3 | Subtype Selective gamma-Aminobutyric Acid Type A Receptor (GABA A R) Modulators Acting at the Benzodiazepine Binding Site: An Update. J Med Chem. 2020 Apr 9;63(7):3425-3446. | ||||
REF 4 | Structure-Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/-Aminobutyric Acid Transporter 1 (BGT1). J Med Chem. 2017 Nov 9;60(21):8834-8846. | ||||
REF 5 | Synthesis and biological evaluation of 4-(aminomethyl)-1-hydroxypyrazole analogues of muscimol as -aminobutyric acid(a) receptor agonists. J Med Chem. 2013 Feb 14;56(3):993-1006. | ||||
REF 6 | Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines a... J Med Chem. 1998 Oct 8;41(21):4130-42. | ||||
REF 7 | Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach. J Med Chem. 2000 Jan 13;43(1):71-95. | ||||
REF 8 | Five-Membered N-Heterocyclic Scaffolds as Novel Amino Bioisosteres at gamma-Aminobutyric Acid (GABA) Type A Receptors and GABA Transporters. J Med Chem. 2019 Jun 27;62(12):5797-5809. | ||||
REF 9 | Synthesis and pharmacological evaluation of 6-aminonicotinic acid analogues as novel GABA(A) receptor agonists. Eur J Med Chem. 2014 Sep 12;84:404-16. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.